apc15 Antibody

What is APC15 and why is it important in cell cycle research?

APC15 is a previously uncharacterized open reading frame (C11orf51) identified through systematic proteomic analysis of APC/C purified from HeLa cell extracts. It is a component of the Anaphase Promoting Complex/Cyclosome (APC/C) required for progression from metaphase during the cell cycle. Its specific function involves driving the turnover of mitotic checkpoint complexes (MCC)-Cdc20, making the spindle-assembly checkpoint responsive to kinetochore attachment. Depleting APC15 prevents Cyclin B1 ubiquitylation and degradation because MCCs become locked onto the APC/C and cannot be released when all kinetochores have attached to the spindle . This crucial role makes APC15 an important target for researchers studying cell cycle regulation and mitotic progression.

What types of APC15 antibodies are currently available for research?

Several types of APC15 antibodies are available for research applications:

• Polyclonal antibodies generated in guinea pig against full-length His-TEVhAPC15 purified from BL21 E.coli

• Polyclonal antibodies generated against the synthetic peptide DEMNDYNESPDDGEV

• Mouse monoclonal IgG2a kappa light chain antibodies (such as H-9) that detect APC15 protein from mouse, rat, and human sources

These antibodies are available in various formats including non-conjugated forms and conjugated versions with agarose, horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and multiple Alexa Fluor® conjugates to accommodate different experimental needs .

What are the primary applications for APC15 antibodies in basic research?

APC15 antibodies are primarily used in the following applications:

• Western blotting (WB) to detect APC15 protein in cell lysates and tissue samples

• Immunoprecipitation (IP) to isolate APC/C complexes for functional studies

• Immunofluorescence (IF) to visualize APC15 localization in cells

• Enzyme-linked immunosorbent assay (ELISA) for quantitative detection

These applications allow researchers to study APC15's role in cell cycle progression, specifically in the regulation of the spindle-assembly checkpoint and mitotic progression. Asynchronous human cell lysates are typically sufficient as controls for these applications .

What is the molecular weight and basic characteristics of human APC15?

Human APC15 has a molecular weight of approximately 14 kDa. It is conserved in vertebrates and invertebrates and has homology to S. pombe APC15 and S. cerevisiae Mnd2. The protein is part of the Anaphase Promoting Complex/Cyclosome and is specifically required for the turnover of mitotic checkpoint complexes. In humans, it was previously identified as the uncharacterized open reading frame C11orf51 before its function was elucidated through proteomic analysis .

How can APC15 antibodies be used to study mitotic checkpoint regulation?

APC15 antibodies can be employed in sophisticated experimental designs to investigate mitotic checkpoint regulation:

• Co-immunoprecipitation studies: APC15 antibodies can be used to pull down APC/C complexes and analyze the associated proteins, particularly focusing on mitotic checkpoint components like CDC20, MAD2, and BUBR1. Research has shown that APC15 depletion leads to accumulation of these checkpoint proteins on the APC/C, particularly during prometaphase .

• Time-course experiments: Researchers can release cells from nocodazole arrest and use APC15 antibodies to track the dynamics of MCC disassembly over time. In control cells, MAD2 and BUBR1 are typically removed from the APC/C within 90 minutes after release, while in APC15-depleted cells, these checkpoint proteins remain bound to the APC/C for extended periods (180+ minutes) .

• Comparative analysis with checkpoint inhibition: Studies have shown that the mitotic delay caused by APC15 depletion can be partially restored by co-depleting MAD2, confirming that APC15 influences mitotic progression through the spindle assembly checkpoint pathway .

These approaches allow researchers to dissect the specific role of APC15 in regulating the responsiveness of the spindle assembly checkpoint to kinetochore attachment.

What experimental approaches can demonstrate the role of APC15 in CDC20 auto-ubiquitylation?

To investigate APC15's role in CDC20 auto-ubiquitylation, researchers can utilize the following methodological approaches:

• In vitro ubiquitylation assays: Isolate APC/C^MCC from control and APC15-depleted cells, then incubate with ubiquitin, E1 and UBCH10. Research has shown that CDC20 ubiquitylation is reduced when APC/C^MCC is isolated from APC15-depleted cells compared to wild-type controls .

• Recombinant APC/C assembly: Generate recombinant APC/C complexes with and without APC15 using baculovirus expression systems in insect cells. This approach has revealed that APC15 is dispensable for the ubiquitylation activity of APC/C^CDC20 and APC/C^CDH1 but is specifically required for CDC20 auto-ubiquitylation when CDC20 is part of the MCC .

• Comparative ubiquitylation substrate analysis: Perform ubiquitylation assays using different substrates (e.g., cyclin-B1 fragment, CDC20) with recombinant APC/C complexes lacking APC15. Research has demonstrated that APC/C without APC15 remains active in supporting cyclin-B1 and CDC20 ubiquitin conjugate formation when activated by CDH1 .

These experimental approaches collectively demonstrate that APC15 is specifically required for the efficient ubiquitylation of CDC20 when it is part of the MCC, but not when CDC20 functions as an activator of the APC/C or as a substrate of APC/C^CDH1.

How can live-cell imaging be combined with APC15 antibody approaches to study mitotic progression?

Combining live-cell imaging with APC15 antibody approaches involves several methodological considerations:

• Experimental setup: Researchers can deplete APC15 by RNAi in cells stably expressing fluorescent markers such as histone H2B tagged with mCherry and β-tubulin tagged with EGFP, then analyze cells by time-lapse fluorescence microscopy. This approach has revealed that in APC15-depleted cells, progression from nuclear envelope breakdown (NEBD) to anaphase onset takes on average more than twice as long as in control cells .

• Quantitative timing analysis: Key mitotic transitions can be measured, including:

  • Time from NEBD to anaphase onset

  • Time from anaphase to cytokinesis

  • Frequency of cells in different mitotic phases

• Correlation with fixed-cell immunofluorescence: Complementary to live imaging, researchers can perform immunofluorescence microscopy of fixed cells using APC15 antibodies alongside other cell cycle markers. This helps validate the live imaging findings and provides molecular context to the observed phenotypes .

This combined approach has demonstrated that APC15 depletion specifically delays prometaphase and metaphase progression without significantly affecting the time from anaphase to cytokinesis, providing evidence for APC15's specific role in early mitotic transitions.

What are the optimal conditions for using APC15 antibodies in immunoprecipitation experiments?

For optimal immunoprecipitation (IP) experiments with APC15 antibodies, researchers should consider the following methodological details:

• Cell lysis conditions: Cells should be lysed for 30 minutes at 4°C in an appropriate lysis buffer. Based on published protocols, an effective lysis buffer composition includes:

  • CytoBuster as the base

  • 20 mM β-glycerophosphate

  • 10 mM Na-pyrophosphate

  • 10 mM NaF

  • 1 mM Na₃VO₄

  • 1 μM okadaic acid

  • 1X complete protease inhibitor cocktail

• Antibody coupling: APC15 antibodies should be crosslinked to protein A beads (such as Affi-prep protein A beads) for efficient immunoprecipitation. Alternatively, when using commercial antibodies like the mouse monoclonal (H-9), pre-conjugated agarose forms may be utilized .

• Washing conditions: After immunoprecipitation, beads should be washed three times in washing buffer containing:

  • 20 mM Tris pH 7.5

  • 150 mM NaCl

  • 10% (v/v) glycerol

  • 0.1% (v/v) Tween-20

• Elution methods: For elution of immunoprecipitated complexes, researchers can use:

  • 2 bead volumes of 1 mg/ml antigenic peptide dissolved in elution buffer (20 mM Tris pH 7.5, 150 mM NaCl, 10% (v/v) glycerol, 0.1% (w/v) octyl-β-D-glucopyranoside)

  • Alternative elution with 100 mM glycine-HCl at pH 2.2

Following these conditions ensures effective isolation of APC15-containing complexes for downstream analyses such as immunoblotting, mass spectrometry, or functional assays.

What controls should be included when using APC15 antibodies in cell cycle research?

When employing APC15 antibodies in cell cycle research, incorporating appropriate controls is essential:

• Cell synchronization controls:

  • Asynchronous human cell lysates serve as general controls for antibody validation

  • Synchronized populations at specific cell cycle stages (G1/S boundary using thymidine, prometaphase using nocodazole) allow for stage-specific analyses

  • Time-course samples following release from synchronization provide dynamic control points

• Depletion/knockout controls:

  • RNAi-mediated depletion of APC15 to validate antibody specificity

  • Co-depletion experiments (e.g., APC15 + MAD2) to establish functional relationships and specificity of phenotypes

• Protein complex controls:

  • Immunoprecipitation of other APC/C subunits (e.g., CDC27) to compare complex composition

  • Recombinant APC/C complexes with and without APC15 to assess specific contributions to activity

• Functional readouts:

  • Cyclin-B1 degradation monitoring

  • CDC27 phosphorylation status

  • Cell cycle progression markers (e.g., pH3Ser10)

These controls ensure experimental rigor and help distinguish between APC15-specific effects and potential artifacts or secondary consequences of experimental manipulations.

How should researchers prepare samples for optimal APC15 detection by Western blotting?

For optimal detection of APC15 by Western blotting, researchers should follow these methodological guidelines:

• Sample preparation:

  • For cell lysates: Use lysis buffer containing protease inhibitors and phosphatase inhibitors as detailed in section 3.1

  • For APC/C complex analysis: Consider immunoprecipitation of APC/C using antibodies against stable components like CDC27 before Western blotting for APC15

• Protein separation conditions:

  • Given the relatively small size of APC15 (14 kDa), use higher percentage (12-15%) SDS-PAGE gels

  • Consider gradient gels (4-20%) when analyzing APC15 in the context of larger APC/C components

  • Run controls with recombinant APC15 or lysates from cells overexpressing APC15 to confirm the correct band identification

• Transfer parameters:

  • Use semi-dry or wet transfer with optimization for small proteins

  • PVDF membranes may provide better retention of small proteins than nitrocellulose

  • Consider adding 10-20% methanol to transfer buffer to enhance small protein binding

• Blocking and antibody incubation:

  • BSA-based blocking solutions (3-5%) may provide lower background than milk for some APC15 antibodies

  • Primary antibody dilutions should be optimized (typical starting ranges: 1:500 to 1:2000)

  • Longer incubation times (overnight at 4°C) may improve sensitivity

• Detection considerations:

  • Enhanced chemiluminescence (ECL) or fluorescent secondary antibodies can be used

  • For multiplexing with other APC/C components, consider using antibodies raised in different host species

These optimized conditions help ensure reliable and specific detection of APC15 in Western blotting experiments.

How can researchers address the challenge of detecting low abundance APC15 in complex samples?

Detecting low abundance proteins like APC15 requires specialized approaches:

• Enrichment techniques:

  • Immunoprecipitate APC/C using antibodies against more abundant APC/C subunits like CDC27 or APC2 before probing for APC15

  • Consider using tandem affinity purification of APC/C complexes using tagged subunits in stable cell lines

  • Cell synchronization in mitosis can increase the relative abundance of APC/C-associated proteins

• Signal enhancement strategies:

  • Use high-sensitivity detection systems such as SuperSignal West Femto

  • Consider tyramide signal amplification for immunofluorescence detection

  • Biotin-streptavidin amplification systems may enhance signal in challenging samples

• Background reduction approaches:

  • Optimize blocking conditions (duration, buffer composition)

  • Include detergents like 0.1% Tween-20 in wash buffers

  • Consider using antibody diluents specifically formulated to reduce background

• Alternative detection methods:

  • Mass spectrometry-based detection following immunoprecipitation can provide higher sensitivity

  • For tissue samples, consider immunohistochemistry with amplification steps rather than direct immunofluorescence

These approaches can substantially improve the detection of low-abundance APC15, especially in complex experimental systems or tissue samples.

What approaches can resolve conflicting results between different APC15 antibodies?

When faced with conflicting results between different APC15 antibodies, researchers should implement a systematic validation strategy:

• Epitope mapping and antibody characterization:

  • Determine the epitopes recognized by different antibodies (e.g., polyclonal antibodies against the synthetic peptide DEMNDYNESPDDGEV versus antibodies against full-length protein)

  • Consider whether post-translational modifications might affect epitope recognition

  • Evaluate antibody cross-reactivity with other APC/C components

• Validation using genetic approaches:

  • Perform RNAi-mediated depletion of APC15 and verify the disappearance of specific bands/signals

  • Use CRISPR/Cas9-mediated knockout cells as definitive negative controls

  • Consider using cells expressing tagged versions of APC15 for parallel detection with anti-tag antibodies

• Comparison across experimental systems:

  • Test antibodies in multiple cell lines to rule out cell-type specific artifacts

  • Compare results in synchronized versus asynchronous populations

  • Evaluate antibody performance in recombinant systems with defined APC15 content

• Functional correlation analysis:

  • Determine whether the observed signals correlate with known APC15 functions

  • Assess co-precipitation of known APC15 interactors

  • Evaluate whether the detected signals change as expected during cell cycle progression

This systematic approach helps resolve discrepancies and identify the most reliable antibodies for specific applications.

How can researchers distinguish between normal variability and experimental artifacts when studying APC15 dynamics during cell cycle progression?

Distinguishing normal biological variability from experimental artifacts in APC15 studies requires rigorous methodological approaches:

• Temporal resolution optimization:

  • Collect samples at sufficient time points during cell cycle progression (e.g., every 15-30 minutes after release from synchronization)

  • Compare multiple synchronization methods (e.g., double thymidine block versus nocodazole arrest) to identify method-specific artifacts

  • Use single-cell approaches like immunofluorescence alongside population-based biochemical methods to capture cell-to-cell variability

• Quantitative controls and normalization:

  • Include loading controls appropriate for cell cycle studies (not just housekeeping proteins that may vary during mitosis)

  • Normalize APC15 signals to stable APC/C components like APC2 or APC4

  • Use ratios of different APC/C components or MCC proteins rather than absolute values

• Multi-method verification:

  • Combine biochemical approaches (immunoblotting, immunoprecipitation) with imaging techniques

  • Correlate protein levels with functional readouts (e.g., substrate ubiquitylation, cell cycle progression)

  • When possible, use live-cell imaging with fluorescently tagged proteins to track dynamics in real-time

• Statistical analysis and reporting:

  • Perform experiments with sufficient biological replicates (minimum n=3)

  • Apply appropriate statistical tests based on data distribution

  • Report variability measures (standard deviation, standard error) alongside means

This comprehensive approach helps researchers distinguish genuine biological phenomena from technical artifacts in APC15 studies.

How might advanced imaging techniques be combined with APC15 antibodies to resolve remaining questions about its spatial dynamics?

Advanced imaging techniques offer promising approaches to investigate APC15 spatial dynamics:

• Super-resolution microscopy applications:

  • Structured illumination microscopy (SIM) can achieve ~100 nm resolution, sufficient to visualize APC15 in the context of kinetochore attachments

  • Stochastic optical reconstruction microscopy (STORM) or photoactivated localization microscopy (PALM) could resolve APC15 localization at even higher resolution (~20 nm)

  • Stimulated emission depletion (STED) microscopy could be used with appropriate fluorophore-conjugated APC15 antibodies to track its dynamics during mitotic progression

• Live-cell imaging strategies:

  • CRISPR/Cas9-mediated endogenous tagging of APC15 with fluorescent proteins for physiological expression level imaging

  • Combination with other fluorescently tagged APC/C components or MCC proteins to track complex assembly/disassembly in real-time

  • Fluorescence recovery after photobleaching (FRAP) to measure APC15 turnover rates within complexes

• Correlative light and electron microscopy (CLEM):

  • Combine fluorescence imaging of APC15 with electron microscopy to place it in the ultrastructural context of mitotic complexes

  • Immunogold labeling with APC15 antibodies for transmission electron microscopy studies

  • Cryo-electron tomography combined with computational averaging to visualize APC15 within native APC/C complexes

These advanced imaging approaches would help resolve outstanding questions about the precise spatial and temporal dynamics of APC15 during mitotic progression and checkpoint regulation.